Does chronic obstructive pulmonary disease increase the risk of prostate cancer? A nationwide population-based study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Department of Health, the Executive Yuan, Republic of China. Cancer Registry Annual Report 2000–2015. Taiwan; 2017 Available from: http://www.hpa.gov.tw/Pages/List.aspx?nodeid=269.
   Google Scholar
• Grönberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859–864. doi:10.1016/S0140-6736(03)12713-412642065
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol. 2011;60(1):106–117. doi:10.1016/j.eururo.2011.03.05521497433
   PubMed Web of Science ®Google Scholar
• Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349(4):366–381. doi:10.1056/NEJMoa03096912878745
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC22561964
   PubMed Web of Science ®Google Scholar
• Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999;5(2):93–99. doi:10.1097/00063198-199903000-0000310813258
   PubMedGoogle Scholar
• Cheng SL, Chan MC, Wang CC, et al. COPD in Taiwan: a national epidemiology survey. Int J Chron Obstruct Pulmon Dis. 2015;10:2459–2467.26648708
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743. doi:10.1016/S0140-6736(09)61069-219716966
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of COPD - 2016. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2016 Available from: https://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/. Accessed August 13, 2019.
   Google Scholar
• Cheng TM. Reflections on the 20th anniversary of Taiwan’s single-payer National Health Insurance System. Health Aff (Millwood). 2015;34(3):502–510. doi:10.1377/hlthaff.2014.133225732502
   PubMed Web of Science ®Google Scholar
• National Health Research Institutes. National Health Insurance Research Database. Available from: http://nhird.nhri.org.tw/date_01.htm. Accessed 10 1, 2018.
   Google Scholar
• Liu JM, Yu CP, Chuang HC, et al. Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases. Prostate Cancer Prostatic Dis. Epub 2019 Jan 28.
   Google Scholar
• Menezes AMB, Perez-Padilla R, Jardim JB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67528-916310554
   PubMed Web of Science ®Google Scholar
• Wu CY, Chen YJ, Ho HJ, et al. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906–1914. doi:10.1001/2012.jama.1197523162861
   PubMed Web of Science ®Google Scholar
• Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5(2):133–138. doi:10.1080/1541255080194134918415812
   PubMedGoogle Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799. doi:10.1016/S0140-6736(07)61383-X17765529
   PubMed Web of Science ®Google Scholar
• Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. doi:10.1378/chest.12-266423880677
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153(1):6–20. doi:10.1038/bjp.2008.2217643134
   PubMed Web of Science ®Google Scholar
• Rahman I, van Schadewijk AA, Crowther AJ, et al. 4-hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(4):490–495. doi:10.1164/rccm.211010112186826
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J. 2002;20(3):556–563. doi:10.1183/09031936.02.0027200212358328
   PubMed Web of Science ®Google Scholar
• Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev. 2008;7(7):567–573. doi:10.1016/j.autrev.2008.04.01918625446
   PubMed Web of Science ®Google Scholar
• Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55(2):114–120. doi:10.1136/thorax.55.8.68510639527
   PubMed Web of Science ®Google Scholar
• Harju T, Kaarteenaho-Wiik R, Soini Y, Sormunen R, Kinnula VL. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers’ lung. Am J Respir Crit Care Med. 2002;166(5):754–759. doi:10.1164/rccm.211201412204877
   PubMed Web of Science ®Google Scholar
• Mohammed A, Gutta V, Ansari MS, Venkata RS, Jamil K. Altered antioxidant enzyme activity with severity and comorbidities of chronic obstructive pulmonary disease (COPD) in South Indian population. COPD Res Pract. 2017;3:4. doi:10.1186/s40749-017-0023-z
   Google Scholar
• Thakur H, Gupta L, Sobti RC, Janmeja AK, Seth A, Singh SK. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep. 2011;38(3):1733–1739. doi:10.1007/s11033-010-0287-820842440
   PubMed Web of Science ®Google Scholar
• Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530–534. doi:10.1164/ajrccm.153.6.86650368564092
   PubMed Web of Science ®Google Scholar
• Chen K, Pociask DA, McAleer JP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One. 2011;6(5):e20333. doi:10.1371/journal.pone.002033321647421
   PubMed Web of Science ®Google Scholar
• Nadiminty N, Lou W, Lee SO, et al. Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci USA. 2006;103(19):7264–7269. doi:10.1073/pnas.050980810316651533
   PubMed Web of Science ®Google Scholar
• Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate. 2000;42(3):239–242.10639195
   PubMed Web of Science ®Google Scholar
• Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene. 2001;20(31):4188–4197. doi:10.1038/sj.onc.120453511464285
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005;127(5):1544–1552. doi:10.1378/chest.127.2.63015888826
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Burke HB, Djakiew D, et al. Human prostate cancer risk factors. Cancer. 2004;101(10 Suppl):2371–2490.15495199
   PubMed Web of Science ®Google Scholar
• Stone RA, Lowe D, Potter JM, Buckingham RJ, Roberts CM, Pursey NJ. Managing patients with COPD exacerbation: does age matter? Age Ageing. 2012;41(4):461–468. doi:10.1093/ageing/afs03922454133
   PubMed Web of Science ®Google Scholar
• Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG. Inhaled anticholinergic drugs and risk of acute urinary retention. BJU Int. 2011;107(8):1265–1272. doi:10.1111/j.1464-410X.2010.09648.x20880196
   PubMed Web of Science ®Google Scholar
• Moul JW, Davis R, Vaccaro JA, Sihelnik SA, Belville WD, McLeod DG. Acute urinary retention associated with prostatic carcinoma. J Urol. 1989;141(6):1375–1377. doi:10.1016/S0022-5347(17)41312-72470926
   PubMed Web of Science ®Google Scholar